Serena Piacentini

Specialization: Endocrinologist
17 years of experience
Speaks:
English, Italian
Workplace: Italy, Rome, Mater Oblia Hospital
Dr. Serena Piacentini specializes in thyroid and parathyroid disorders, with research focused on endocrine system dysfunctions at the Catholic University of the Sacred Heart in Rome.
- Specialist in Endocrinology and Metabolic Diseases
- PhD from one of Italy's top medical schools
- Research covers a wide range of endocrine disorders

Doctor's services

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Dr. Serena Piacentini is a specialist in endocrinology and metabolic diseases at Mater Olbia Hospital. She holds a PhD from the Catholic University of the Sacred Heart in Rome. The doctor treats hormonal disorders and metabolic conditions for adults and children.

Specialization and Areas of Focus

Dr. Piacentini treats conditions affecting the endocrine system. She conducts diagnostics of the thyroid to treat autoimmune thyroiditis and toxic goiter. Her metabolic practice includes treating diabetes type 2 and dyslipidemia — a condition involving unhealthy levels of blood fats.

The specialist also treats disorders of the adrenal and parathyroid glands. She helps patients with hypothalamic-pituitary issues and neuroendocrine tumors. Her work includes osteoporosis management and correcting menstrual cycle dysfunctions.

Pediatric Endocrinology

The doctor provides care for children with hormonal imbalances. She performs pediatric check-ups to monitor growth and metabolic health. This work lets her detect endocrine disorders early in young patients.

Education and Academic Background

Degree in Medicine and Surgery – Catholic University of the Sacred Heart, Rome
PhD in Endocrinology – Catholic University of the Sacred Heart, Rome
Specialization in Endocrinology and Metabolic Diseases

Clinical Research

Dr. Piacentini researches treatments for adrenal and thyroid disorders. Her work explores metabolic bone diseases and the treatment of neuroendocrine tumors. This academic focus lets her use current data in her clinical practice.